Pharma & Biotech VC & Investment News
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Today's issue
Refine Search
Biotechnology
The growing stable of Flagship Pioneering now has another member, with this one purportedly the world’s first exoneural biology company. 8 October 2019
Pharmaceutical
Icosavax has announced the launch of the company with a $51 million Series A financing, led by Qiming Venture Partners USA and joined by Adams Street Partners, Sanofi Ventures and NanoDimension, with continuing support from its seed investors. 4 October 2019
Biotechnology
California, USA-based discovery start-up Tenaya Therapeutics today announced the successful completion of a $92 million Series B financing. 3 October 2019
Biotechnology
A report from the UK BioIndustry Association (BIA) finds that investment in UK biotech companies is slowing, with a total of £869 million ($1 billion) being raised for the year up to 31 August. 2 October 2019
Biotechnology
Health Sciences Acquisitions Corp and Immunovant Sciences, a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases and a member of Switzerland's Roivant family of companies, today announced that they have entered into a definitive share exchange agreement (SEA). 2 October 2019
Biotechnology
Shares of clinical-stage US biotech Provention Bio rose 6% in pre-market trading in reaction to reiteration of its registration plan for its Breakthrough Therapy-designated teplizumab (PRV-031) for the prevention or delay of clinical type 1 diabetes in at-risk people 24 September 2019
Biotechnology
Edgewise Therapeutics is now $50 million better off after a Series B financing. 18 September 2019
Pharmaceutical
A new commercial licensing agreement between Bayer and digital therapeutic specialist One Drop will give the German pharma major access to an integrated platform for tracking and managing health conditions. 17 September 2019
Biotechnology
While there are several commonly-cited reasons for the present pre-eminence of the Cambridge-Boston biotech cluster, it's clear that the hub is greater than the sum of its parts. 16 September 2019
Pharmaceutical
Howard Rowe, managing director and head of healthcare, Hayfin Capital Management, considers the impact of divestments necessitated by big companies' major acquisitions, in an Expert View piece. 5 September 2019
Biotechnology
Drug development accelerator BioMotiv and pharma major Bristol-Myers Squibb have announced a new strategic partnership. 5 September 2019
Biotechnology
Investors in the Atlas Venture-backed immuno-oncology specialist Surface Oncology have had a rough time since the company went public in New York, early in 2018. 5 September 2019
Biotechnology
UK biotech start-up Achilles Therapeutics says it has closed a £100 million ($120.6 million) Series B financing led by incoming US investor RA Capital Management, corner-stoned by founding investor Syncona and joined by important new investors including Forbion, Invus, Perceptive Advisors and Redmile Group. 3 September 2019
Pharmaceutical
Canada-headquartered ESSA Pharma said on Tuesday that, further to its previously announced equity offering, it has closed a public offering of the firm’s equity securities in Canada and a concurrent private placement of equity securities in the USA for aggregate gross proceeds of $36 million. 28 August 2019
Pharmaceutical
A start-up set up by US pharma giant Pfizer to take forward a number of drug programs, is planning an initial public offering (IPO). 19 August 2019
Biotechnology
European life sciences investment firm Medicxi today announces the closing of Medicxi III, a new 400 million-euro ($488 million) fund. This brings the total amount raised by Medicxi in the last three years to over $1 billion. 19 July 2019
Biotechnology
The global advanced therapy medicinal product (ATMP) sector is growing rapidly, with more than 900 developers active in this space, sponsoring 1,060 clinical trials, including 93 Phase III studies. 18 July 2019
Pharmaceutical
Denmark’s Sunstone Life Science Ventures has invested five million euros ($5.6 million) out of its Life Science Ventures Fund IV into Forendo Pharma, a Finnish clinical-stage drug development company focusing on novel treatments in women's health. 17 July 2019
Biotechnology
Dutch kidney specialist AM-Pharma has raised 116 million euros ($133 million) from a European syndicate of new and existing investors. 16 July 2019
Biotechnology
An outsized series B funding round will surely nix rumors that Europe’s largest privately-held biotech is about to list on the Nasdaq. 9 July 2019
Biotechnology
California-based venture capital firm Versant Ventures yesterday announced the launch of Pep2Tango Therapeutics, a start-up focused on innovative, next-generation weight loss therapies. Proceeds from the significant, undisclosed round will support development of the company’s novel unimolecular tetra-receptor agonist peptides to treat obesity and related conditions. 22 November 2024
Biotechnology
Hong Kong-based Sino Biopharm has signed an equity investment and strategic collaboration agreement with LaNova Medicines, advancing its oncology focus. 22 November 2024
Biotechnology
Colorado, USA-based biotech Enveda Biosciences, which is using AI to translate nature into new medicines, has announced an oversubscribed $130 million Series C funding round led by Kinnevik and FPV. 22 November 2024
Biotechnology
San Diego-based Cidara Therapeutics, a biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, has entered into a securities purchase agreement with certain investors to raise up to around $105 million. 21 November 2024
Biotechnology
Aizen Therapeutics, an AI-driven biotech headquartered in San Diego, has officially launched from stealth mode, introducing its drug discovery platform, DaX. 21 November 2024
Biotechnology
San Diego-based Valora Therapeutics, a biotech that boasts of having a novel approach to immunotherapy, has announced the successful closing of a $30 million seed funding round. 21 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
Shanghai-based Leading Tac Pharmaceutical has announced the successful completion of a series A financing round, raising over 100 million yuan ($14 million). 21 November 2024
Biotechnology
A pair of industry veterans have teamed up to create Jupiter Bioventures, a San Francisco-based biotech venture foundry promised to build bold, science-driven therapeutics companies. 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Californian oncology-focused biotech Avenzo Therapeutics has announced a pair of important updates. 19 November 2024
Pharmaceutical
In yet another sign of the mounting interest in radiopharmaceuticals, Tongrui Biopharma, a Chinese innovator in this area, has announced the completion of a $100 million series A+ financing round. 18 November 2024
Biotechnology
Shanghai-based biopharma Zai Lab has announced the pricing of its underwritten public offering at $25.50 per share, aiming to raise around $200 million. 15 November 2024
Pharmaceutical
New York-based Metsera, a biopharma developing medicines for obesity and metabolic diseases, has closed a $215 million Series B financing to further advance its portfolio of clinical-stage, nutrient-stimulated hormone (NuSH) analog peptides. 14 November 2024
Pharmaceutical
Life science investor Syncona has announced the launch of its newest portfolio company, Slingshot Therapeutics, through the Syncona Accelerator initiative. 14 November 2024
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Biotechnology
Trace Neuroscience, a newly launched biopharma based in San Francisco, aims to advance treatments for neurodegenerative diseases, starting with amyotrophic lateral sclerosis (ALS). 12 November 2024
Biotechnology
Geron Corporation, a biopharma company focused on telomerase inhibition therapies, has announced a $375 million financing agreement aimed at supporting the commercial rollout of Rytelo (imetelstat). 11 November 2024
Biotechnology
An Expert View from Cumulus Oncology about its innovative business model, which is all about improving the efficiency of drug R&D. 11 November 2024
Biotechnology
US biotech venture fund Aditum Bio and China’s Leads Biolabs today announced the formation of Oblenio Bio, marking the thirteenth company launched by Aditum. 7 November 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze